基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
对 Fukui 等人所著‘治疗后 TIL（肿瘤浸润淋巴细胞）增加与雌激素受体阳性/HER2 阴性乳腺癌新辅助内分泌治疗反应不佳显著相关’一文的评论
英文原题：Comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
查看英文原题
Comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
这是对Fukui等人研究TIL（肿瘤浸润淋巴细胞）（TILs）与雌激素受体阳性/HER2阴性乳腺癌新辅助内分泌治疗反应之间关系的文章的评论。虽然他们的数据相当有趣，但一些对解释本研究结果至关重要的信息缺失。因此，我希望作者能提供额外数据。
展开英文摘要原文
This is a comment on the article by Fukui et al. investigating the relationship between tumor-infiltrating lymphocytes (TILs) and response to neoadjuvant endocrine therapy in estrogen receptor-positive/HER2-negative breast cancer. While their data are quite interesting, some information crucial for interpreting the results of this study is missing.
Therefore, I would like the authors to provide additional data.
论文信息
- 作者
- Horimoto Y
- 单位
- Department of Breast Surgery and Oncology, Tokyo Medical University, 6‑1‑1 Shinjuku, Shinjuku‑ku, Tokyo, 160‑8402, Japan. horimoto.yoshiya.4m@tokyo-med.ac.jp.Japan
- 文献类型
- 读者来信 · 评论
- 期刊
- Breast cancer (Tokyo, Japan)2024 Jan
- 原文标识
- PubMed 37985622 · DOI 10.1007/s12282-023-01527-5